Bellevue Group AG SAGE Holdings History
Bellevue Group AG's Sage Therapeutics Inc Holding Summary
As of 2025-03-31, Bellevue Group AG held - shares of Sage Therapeutics Inc(SAGE), totaling N/A. This investment constitutes 0% of their stock portfolio, and Bellevue Group AG now holds 0% of the outstanding Sage Therapeutics Inc(SAGE) stock.
The initial trade took place in 2018Q2. And since then Bellevue Group AG has made 13 purchases of SAGE, at an average price of $79.75, for a total of 4.76 Mil shares. In addition, there have been 13 sales at an average price of $9.73 for 4.76 Mil shares. Based on historical transaction data and SAGE's current price of $8.75, Bellevue Group AG's estimated gain on his SAGE holdings is $-333.16 Mil, reflecting a -87.80% gain to date.
Bellevue Group AG SAGE ($8.75) Holding Chart
Bellevue Group AG SAGE ($8.75) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
